Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Gains from Sales and Divestitures (2022 - 2023)

Updated

Abeona Therapeutics' Gains from Sales and Divestitures came in at -$152.37 million for FY2025, compared with $2,000 in FY2024.

Analysis

Abeona Therapeutics (ABEO) Gains from Sales and Divestitures (2022 - 2023) Analysis & Trends

Going back to FY2017, Abeona Therapeutics' Gains from Sales and Divestitures data covers 5 years.

  • The FY2025 figure represents the lowest annual Gains from Sales and Divestitures in data going back to FY2017.
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at $2,000 in FY2024, -$47,000 in FY2023 and -$138,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5,000.00
Sep 30, 2023 -5,000.00
Dec 31, 2022 -17,000.00
Sep 30, 2022 -15,000.00
API Access

Abeona Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ABEO&period=max&api_key=YOUR_API_KEY